Analyst Price Target is $4.00
▲ +122.22% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for XpresSpa Group in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 122.22% upside from the last price of $1.80.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in XpresSpa Group.
XpresSpa Group, Inc. is a health and wellness services company. The firm operates through the following brands: Treat, XpresCheck, and XpresSpa. The Treat brand is a travel health and wellness brand that focuses on providing on-demand access to healthcare through technology and personalized services. The XpresCheck brand is an on-site airport provider of COVID-19 screening and testing in domestic airports. The XpresSpa brand is an airport retailer of spa services and related health and wellness products in airports globally. The company was founded by Jonathan Medved and David Goldfarb in January 9, 2006 and is headquartered in New York, NY.